AbbVie stock fell on its $63 billion plan to acquire Botox-maker Allergan, which helps the pharmaceutical company diversify as Humira patents expire. So, is ABBV stock a buy right now?

source https://finance.yahoo.com/m/cc8420fe-01f8-3e0b-85b4-85ff830fff37/abbvie-stock-is-poised-to.html?.tsrc=rss